Reportlinker Adds North America Nephrology and Urology Devices Market Outlook to 2017

News provided by

Apr 12, 2011, 07:17 ET

NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

North America Nephrology and Urology Devices Market Outlook to 2017

http://www.reportlinker.com/p0334117/North-America-Nephrology-and-Urology-Devices-Market-Outlook-to-2017.html

North America Nephrology and Urology Devices Market Outlook to 2017

Summary

GlobalData's new report, "North America Nephrology and Urology Devices Market Outlook to 2017" provides key market data on the North America Nephrology and Urology Devices market – Canada and United States. The report provides value (USD million) data for all the market categories – Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Canada and United States.

- Market size and company share data for Nephrology and Urology Devices market categories – Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the North America Nephrology and Urology Devices market.

- Key players covered include Fresenius Medical Care AG & Co. KGaA, Kimberly-Clark Corporation, Baxter International Inc., Gambro AB, First Quality Enterprises, Inc, Svenska Cellulosa Aktiebolaget SCA,. and others

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the North America Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 10

2.1 What is This Report About? 10

3 Nephrology and Urology Devices in North America 11

3.1 Nephrology and Urology Devices, Cross Country Comparison, Revenue ($m), 2003-2017 11

3.2 Nephrology and Urology Devices, North America, Overall Revenue ($m), 2003-2017 12

3.3 Nephrology and Urology Devices, North America, Category Volume (Units), 2003-2017 19

3.4 Nephrology and Urology Devices, North America, Company share (2009-2010) 24

4 Nephrology and Urology Devices In United States 26

4.1 Nephrology and Urology Devices, United States, Overall Revenue ($m), 2003-2017 26

4.2 Nephrology and Urology Devices, United States, Category Volume (Units), 2003-2017 32

4.3 Nephrology and Urology Devices, United States, Distribution Share (2009-2010) 37

4.3.1 Incontinence Devices, United States, Distribution Share (2009-2010) 37

4.3.2 Lithotripters, United States, Distribution Share (2009-2010) 37

4.3.3 Renal Dialysis Equipment, United States, Distribution Share (2009-2010) 38

4.4 Nephrology and Urology Devices, United States, Company Share (2009-2010) 39

4.4.1 Nephrology and Urology Devices, United States, Company Share (2009-2010) 39

4.4.2 Incontinence Devices, United States, Company Share (2009-2010) 41

4.4.3 Lithotripters, United States, Company Share (2009-2010) 43

4.4.4 Renal Dialysis Equipment, United States, Company Share (2009-2010) 45

5 Nephrology and Urology Devices In Canada 47

5.1 Nephrology and Urology Devices, Canada, Overall Revenue ($m), 2003-2017 47

5.2 Nephrology and Urology Devices, Canada, Category Volume (Units), 2003-2017 51

5.3 Nephrology and Urology Devices, Canada, Distribution Share (2009-2010) 56

5.3.1 Incontinence Devices, Canada, Distribution Share (2009-2010) 56

5.3.2 Lithotripters, Canada, Distribution Share (2009-2010) 56

5.3.3 Renal Dialysis Equipment, Canada, Distribution Share (2009-2010) 57

5.4 Nephrology and Urology Devices, Canada, Company Share (2009-2010) 58

5.4.1 Nephrology and Urology Devices, Canada, Company Share (2009-2010) 58

5.4.2 Incontinence Devices, Canada, Company Share (2009-2010) 60

5.4.3 Lithotripters, Canada, Company Share (2009-2010) 62

5.4.4 Renal Dialysis Equipment, Canada, Company Share (2009-2010) 64

6 Overview of Key Companies in North America Nephrology and Urology Devices Market 66

6.1 Fresenius Medical Care AG & Co. KGaA 66

6.1.1 Company Overview 66

6.1.2 Share in the North America Nephrology and Urology Devices Market 66

6.2 Kimberly-Clark Corporation 67

6.2.1 Company Overview 67

6.2.2 Share in the North America Nephrology and Urology Devices Market 67

6.3 Baxter International Inc. 68

6.3.1 Company Overview 68

6.3.2 Share in the North America Nephrology and Urology Devices Market 68

6.4 Gambro AB 69

6.4.1 Company Overview 69

6.4.2 Share in the North America Nephrology and Urology Devices Market 69

6.5 First Quality Enterprises, Inc. 70

6.5.1 Company Overview 70

6.5.2 Share in the North America Nephrology and Urology Devices Market 70

6.6 Svenska Cellulosa Aktiebolaget SCA 71

6.6.1 Company Overview 71

6.6.2 Share in the North America Nephrology and Urology Devices Market 71

6.7 NxStage Medical, Inc. 72

6.7.1 Company Overview 72

6.8 C. R. Bard, Inc. 72

6.8.1 Company Overview 72

6.9 B. Braun Melsungen AG 73

6.9.1 Company Overview 73

6.10 HARTMANN GROUP 73

6.10.1 Company Overview 73

6.11 Covidien plc 73

6.11.1 Company Overview 73

6.12 Teleflex Incorporated 74

6.12.1 Company Overview 74

6.13 NIPRO CORPORATION 74

6.13.1 Company Overview 74

6.14 Medline Industries, Inc. 74

6.14.1 Company Overview 74

6.15 Coloplast A/S 75

6.15.1 Company Overview 75

6.16 Asahi Kasei Corporation 75

6.16.1 Company Overview 75

6.17 Dornier MedTech GmbH 75

6.17.1 Company Overview 75

6.18 STORZ MEDICAL AG 76

6.18.1 Company Overview 76

6.19 EDAP TMS S.A. 76

6.19.1 Company Overview 76

6.20 Siemens Healthcare 76

6.20.1 Company Overview 76

7 Nephrology and Urology Devices Market Pipeline Products 77

8 Financial Deals Landscape 79

8.1 Acquisition 79

8.1.1 Fenner Acquires MRI Manufacturing & Research 79

8.1.2 K-Kitz Acquires Bacterin In Reverse Acquisition 80

8.1.3 Endo Pharmaceuticals Holding Completes Acquisition Of HealthTronics 81

8.2 Partnerships 83

8.2.1 Quick-Med Technologies Enters Into Co-Development Agreement With Foster 83

8.2.2 Argon Medical Devices Enters Into An Agreement With Rex Medical 84

8.2.3 Interface Biologics Signs Exclusive License Option Agreement With Fresenius Medical Care 85

8.2.4 AorTech International Enters Into Technology License Agreement 86

8.2.5 Boston Scientific Enters Into Co-Marketing Agreement With Bladder Health Network 87

9 Recent Developments 88

9.1 Strategy and Business Planning 88

9.1.1 Feb 10, 2011: C. R. Bard To Reduce Workforce By 20% 88

9.1.2 Jan 18, 2011: Eigen Completes Restructuring Plan For Urology Marketplace 88

9.1.3 Dec 13, 2010: Bard To Improve Overall Cost Structure And Enhance Operational Effectiveness 88

9.1.4 Aug 19, 2010: Boston Scientific To Invest In New Products: CEO 88

9.1.5 Aug 09, 2010: Zurex Establishes Headquarters In Madison, Wisconsin 89

9.1.6 Jun 17, 2010: Baxter Opens New Research & Development Facility In Alliance Park, Belgium 89

9.1.7 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany 90

9.1.8 Apr 29, 2010: Boston Scientific Launches Pelvic Floor Institute For Urology, Women Health Procedures 90

9.1.9 Mar 23, 2010: Nephros Signs Development Agreement With STERIS 91

9.2 Legal and Regulatory 91

9.2.1 Jan 11, 2011: Boston Scientific Reaches Settlement With Medinol 91

9.2.2 Sep 21, 2010: Robbins Geller Files Class Action Suit Against Baxter 91

9.2.3 Jun 21, 2010: HealthTronics Announces Agreement To Settle Shareholder Lawsuits 92

9.2.4 Jun 09, 2010: Mentor Settles ObTape Vaginal Sling Liability cases 93

9.2.5 Apr 09, 2010: Robbins Geller Files Class Action Suit Against Boston Scientific 93

9.3 Government and Public Interest 94

9.3.1 Jan 28, 2011: Baxter Receives FDA Warning Letter Regarding Violations At Two Manufacturing Plants In Puerto Rico 94

9.3.2 Jan 14, 2011: FMCNA Initiates Voluntary Recall Of CombiSet True Flow Series Hemodialysis Blood Tubing Set With Priming Set And Transducer Protectors For Use With Blood Volume Monitor 94

9.3.3 Dec 21, 2010: Boston Scientific Receives Notices Of Deficiency From IRS 95

9.3.4 Nov 22, 2010: Landmark Study In New England Journal Of Medicine Documents Significant Clinical Advantages Of More Frequent Hemodialysis: NxStage 95

9.3.5 Oct 26, 2010: Interface Biologics Receives ISO 13485:2003 Certification 96

9.3.6 Oct 06, 2010: FDA Issues Warning Letter To Fresenius Medical Care Over Faulty Kidney Devices 97

9.3.7 Sep 30, 2010: South Asians At Twice Risk Of Heart Attack And Death After Transplant: St. Michael's Hospital Study 97

9.3.8 Sep 27, 2010: CytoSorbents Achieves ISO 13485 Certification 98

9.3.9 Sep 02, 2010: UCSF Unveils Model For Implantable Artificial Kidney To Replace Dialysis 98

9.3.10 Sep 02, 2010: UCSF Researchers Unveil Prototype Model Of First Implantable Artificial Kidney 100

9.3.11 Aug 11, 2010: Boston Scientific Resolves Corporate Warning Letter 100

9.3.12 Jun 29, 2010: FDA Issues Warning Letter To Baxter Over Reporting Process 101

9.3.13 Jun 07, 2010: Duplex Guided Dialysis Access Angioplasty Safe In Office Setting: Study 101

9.3.14 May 29, 2010: Mayo Clinic Research Finds Surgery Outperforms Drug Therapy In Treatment Of Benign Prostatic Hyperplasia 102

9.3.15 May 28, 2010: Urologix Presents Two Clinical Abstracts At Geriatric Urological Society During AUA 2010 Annual Meeting 103

9.3.16 May 17, 2010: Baxter Announces Voluntary Recall Of HYLENEX 104

9.3.17 Apr 20, 2010: FDA To Address Challenges Of Using Complex Medical Devices In Home 104

9.4 Product News 106

9.4.1 Apr 07, 2010: Preclinical Study Finds Cause Of Chronic Kidney Disease In Kids 106

10 Appendix 107

10.1 Definitions of Markets Covered in the Report 108

10.1.1 Nephrology and Urology Devices 108

10.2 Research Methodology 109

10.3 Secondary Research 109

10.4 Primary Research 110

10.5 Models 110

10.6 Forecasts 111

10.7 Expert Panels 111

10.8 GlobalData Consulting 111

10.9 Currency Conversion 111

10.10 Contact Us 112

10.11 Disclaimer 112

1.1 List of Tables

Table 1: Nephrology and Urology Devices, Cross Country Comparison, Revenue ($m), 2003-2017 11

Table 2: Nephrology and Urology Devices, North America, Overall Revenue ($m), 2003-2017 13

Table 3: Nephrology and Urology Devices, North America, Cross-Category Analysis, 2003-2017 14

Table 4: Nephrology and Urology Devices, North America, Overall Revenue ($m), Historic, 2003-2010 16

Table 5: Nephrology and Urology Devices, North America, Overall Revenue ($m), Forecast, 2010-2017 18

Table 6: Nephrology and Urology Devices, North America, Category Volume (Units), 2003-2017 19

Table 7: Nephrology and Urology Devices, North America, Category Volume (Units), Historic, 2003-2010 21

Table 8: Nephrology and Urology Devices, North America, Category Volume (Units), Forecast, 2010-2017 23

Table 9: Nephrology and Urology Devices, North America, Company share by Revenue ($m), 2009-2010 25

Table 10: Nephrology and Urology Devices, United States, Overall Revenue ($m), 2003-2017 27

Table 11: Nephrology and Urology Devices, United States, Overall Revenue ($m), Historic, 2003-2010 29

Table 12: Nephrology and Urology Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 31

Table 13: Nephrology and Urology Devices, United States, Category Volume (Units), 2003-2017 32

Table 14: Nephrology and Urology Devices, United States, Category Volume (Units), Historic, 2003-2010 34

Table 15: Nephrology and Urology Devices, United States, Category Volume (Units), Forecast, 2010-2017 36

Table 16: Incontinence Devices, AAWUnited States, Distribution Share by Revenue ($m), 2009-2010 37

Table 17: Lithotripters, United States, Distribution Share by Revenue ($m), 2009-2010 37

Table 18: Renal Dialysis Equipment, United States, Distribution Share by Revenue ($m), 2009-2010 38

Table 19: Nephrology and Urology Devices, United States, Company Share by Revenue ($m), 2009-2010 40

Table 20: Incontinence Devices, United States, Company Share by Revenue ($m), 2009-2010 42

Table 21: Lithotripters, United States, Company Share by Revenue ($m), 2009-2010 44

Table 22: Renal Dialysis Equipment, United States, Company Share by Revenue ($m), 2009-2010 46

Table 23: Nephrology and Urology Devices, Canada, Overall Revenue ($m), 2003-2017 47

Table 24: Nephrology and Urology Devices, Canada, Overall Revenue ($m), Historic, 2003-2010 48

Table 25: Nephrology and Urology Devices, Canada, Overall Revenue ($m), Forecast, 2010-2017 50

Table 26: Nephrology and Urology Devices, Canada, Category Volume (Units), 2003-2017 51

Table 27: Nephrology and Urology Devices, Canada, Category Volume (Units), Historic, 2003-2010 53

Table 28: Nephrology and Urology Devices, Canada, Category Volume (Units), Forecast, 2010-2017 55

Table 29: Incontinence Devices, Canada, Distribution Share by Revenue ($m), 2009-2010 56

Table 30: Lithotripters, Canada, Distribution Share by Revenue ($m), 2009-2010 56

Table 31: Renal Dialysis Equipment, Canada, Distribution Share by Revenue ($m), 2009-2010 57

Table 32: Nephrology and Urology Devices, Canada, Company Share by Revenue ($m), 2009-2010 59

Table 33: Incontinence Devices, Canada, Company Share by Revenue ($m), 2009-2010 61

Table 34: Lithotripters, Canada, Company Share by Revenue ($m), 2009-2010 63

Table 35: Renal Dialysis Equipment, Canada, Company Share by Revenue ($m), 2009-2010 65

Table 36: Nephrology and Urology Devices Market Pipeline Products 77

Table 37: Fenner Acquires MRI Manufacturing & Research 79

Table 38: K-Kitz Acquires Bacterin In Reverse Acquisition 80

Table 39: Endo Pharmaceuticals Holding Completes Acquisition Of HealthTronics 81

Table 40: Quick-Med Technologies Enters Into Co-Development Agreement With Foster 83

Table 41: Argon Medical Devices Enters Into An Agreement With Rex Medical 84

Table 42: Interface Biologics Signs Exclusive License Option Agreement With Fresenius Medical Care 85

Table 43: AorTech International Enters Into Technology License Agreement 86

Table 44: Boston Scientific Enters Into Co-Marketing Agreement With Bladder Health Network 87

Table 45: USD to Local Currency, North America, Average Exchange Rate 2003-20010 111

1.2 List of Figures

Figure 1: Nephrology and Urology Devices, Cross Country Comparison, Revenue ($m), 2003-2017 11

Figure 2: Nephrology and Urology Devices, North America, Overall Revenue ($m), 2003-2017 12

Figure 3: Nephrology and Urology Devices, North America, Cross-Category Analysis, 2003-2017 14

Figure 4: Nephrology and Urology Devices, North America, Overall Revenue ($m), Historic, 2003-2010 15

Figure 5: Nephrology and Urology Devices, North America, Overall Revenue ($m), Forecast, 2010-2017 17

Figure 6: Nephrology and Urology Devices, North America, Category Volume (Units), 2003-2017 19

Figure 7: Nephrology and Urology Devices, North America, Category Volume (Units), Historic, 2003-2010 20

Figure 8: Nephrology and Urology Devices, North America, Category Volume (Units), Forecast, 2010-2017 22

Figure 9: Nephrology and Urology Devices, North America, Company share (%), 2010 24

Figure 10: Nephrology and Urology Devices, United States, Overall Revenue ($m), 2003-2017 26

Figure 11: Nephrology and Urology Devices, United States, Overall Revenue ($m), Historic, 2003-2010 28

Figure 12: Nephrology and Urology Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 30

Figure 13: Nephrology and Urology Devices, United States, Category Volume (Units), 2003-2017 32

Figure 14: Nephrology and Urology Devices, United States, Category Volume (Units), Historic, 2003-2010 33

Figure 15: Nephrology and Urology Devices, United States, Category Volume (Units), Forecast, 2010-2017 35

Figure 16: Nephrology and Urology Devices, United States, Company Share (%), 2010 39

Figure 17: Incontinence Devices, United States, Company Share (%), 2010 41

Figure 18: Lithotripters, United States, Company Share (%), 2010 43

Figure 19: Renal Dialysis Equipment, United States, Company Share (%), 2010 45

Figure 20: Nephrology and Urology Devices, Canada, Overall Revenue ($m), 2003-2017 47

Figure 21: Nephrology and Urology Devices, Canada, Overall Revenue ($m), Historic, 2003-2010 48

Figure 22: Nephrology and Urology Devices, Canada, Overall Revenue ($m), Forecast, 2010-2017 49

Figure 23: Nephrology and Urology Devices, Canada, Category Volume (Units), 2003-2017 51

Figure 24: Nephrology and Urology Devices, Canada, Category Volume (Units), Historic, 2003-2010 52

Figure 25: Nephrology and Urology Devices, Canada, Category Volume (Units), Forecast, 2010-2017 54

Figure 26: Nephrology and Urology Devices, Canada, Company Share (%), 2010 58

Figure 27: Incontinence Devices, Canada, Company Share (%), 2010 60

Figure 28: Lithotripters, Canada, Company Share (%), 2010 62

Figure 29: Renal Dialysis Equipment, Canada, Company Share (%), 2010 64

Figure 30: Fresenius Medical Care AG & Co. KGaA, Company Share (%), North America Nephrology and Urology Devices Market, 2010 66

Figure 31: Kimberly-Clark Corporation, Company Share (%), North America Nephrology and Urology Devices Market, 2010 67

Figure 32: Baxter International Inc., Company Share (%), North America Nephrology and Urology Devices Market, 2010 68

Figure 33: Gambro AB, Company Share (%), North America Nephrology and Urology Devices Market, 2010 69

Figure 34: First Quality Enterprises, Inc., Company Share (%), North America Nephrology and Urology Devices Market, 2010 70

Figure 35: Svenska Celulosa Aktiebolaget SCA, Company Share (%), North America Nephrology and Urology Devices Market, 2010 71Fresenius Medical Care AG & Co. KGaA

Kimberly-Clark Corporation

Baxter International Inc.

Gambro AB

First Quality Enterprises, Inc.

Svenska Cellulosa Aktiebolaget SCA

NxStage Medical, Inc.

C. R. Bard, Inc.

B. Braun Melsungen AG

HARTMANN GROUP

Covidien plc

Teleflex Incorporated

NIPRO CORPORATION